Full View

Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans

PJ Klasse, DF Nixon, JP Moore - Science advances, 2021 - science.org
Multiple preventive vaccines are being developed to counter the coronavirus disease 2019
pandemic. The leading candidates have now been evaluated in nonhuman primates (NHPs) …
被引用次数：114 相关文章

Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans.

PJ Klasse, DF Nixon, JP Moore - 2021 - cabidigitallibrary.org
Multiple preventive vaccines are being developed to counter the coronavirus disease 2019
pandemic. The leading candidates have now been evaluated in nonhuman primates (NHPs) …

Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans

PJ Klasse, DF Nixon, JP Moore - Science advances, 2021 - pubmed.ncbi.nlm.nih.gov
Multiple preventive vaccines are being developed to counter the coronavirus disease 2019
pandemic. The leading candidates have now been evaluated in nonhuman primates (NHPs) …
[PDF] scienceopen.com

[PDF][PDF] Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans

PJ Klasse, DF Nixon, JP Moore - 2021 - scienceopen.com
Multiple preventive vaccines are being developed to counter the coronavirus disease 2019
pandemic. The leading candidates have now been evaluated in nonhuman primates (NHPs) …

Immunogenicity of Clinically Relevant SARS-CoV-2 Vaccines in Non-human Primates and Humans

PJ Klasse, DF Nixon, JP Moore - 2020 - preprints.org
Multiple preventive vaccines are being developed to counter the COVID-19 pandemic. The
leading candidates have now been evaluated in non-human primates (NHPs) and human …

Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans.

PJ Klasse, DF Nixon, JP Moore - Science Advances, 2021 - europepmc.org
Multiple preventive vaccines are being developed to counter the coronavirus disease 2019
pandemic. The leading candidates have now been evaluated in nonhuman primates (NHPs) …
[PDF] academia.edu

[PDF][PDF] Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans

PJ Klasse, DF Nixon, JP Moore - 2021 - academia.edu
Multiple preventive vaccines are being developed to counter the coronavirus disease 2019
pandemic. The leading candidates have now been evaluated in nonhuman primates (NHPs) …

[引用][C] Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans

PJ Klasse, DF Nixon, JP Moore - Science Advances, 2021 - ui.adsabs.harvard.edu
Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and
humans - NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS …
[HTML] nih.gov

[HTML][HTML] Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans

PJ Klasse, DF Nixon, JP Moore - Science Advances, 2021 - ncbi.nlm.nih.gov
Multiple preventive vaccines are being developed to counter the coronavirus disease 2019
pandemic. The leading candidates have now been evaluated in nonhuman primates (NHPs) …

Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans.

PJ Klasse, DF Nixon, JP Moore - Science Advances, 2021 - europepmc.org
Multiple preventive vaccines are being developed to counter the coronavirus disease 2019
pandemic. The leading candidates have now been evaluated in nonhuman primates (NHPs) …